Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Gabapentin NDC 16571-226 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text provides information about pain scores for different groups over a 4-3 week dose titration period and a 4-week fixed dose period. It includes details on a placebo group, a Gabapentin group receiving 1800 mg/day, and a Gabapentin group receiving 2400 mg/day. The data seems to be part of a study or research on pain management.*
The text provided contains information about the proportion of responders in controlled post-herpetic neuralgia (PHN) studies for two different treatments. Study 1 shows 34% of responders with the placebo and 52% with GBP 3600, while Study 2 shows percentages of 5% for placebo, 82% for GBP 800, and 80% for GBP 2400. The statistical significance is indicated as p<0.01 and p<0.0001 for the two studies respectively.*
This text provides information about Gabapentin tablets containing 600 mg manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India for Rising Pharma Holdings, Inc. It includes dosage and usage details, storage instructions, and a link to a medication guide for patients. The tablets are to be dispensed in child-resistant containers at controlled room temperature.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.